Bernd Meibohm, Ph.D. is a Professor of Pharmaceutical Sciences and Associate Dean for Research and Graduate Programs at the College of Pharmacy, The University of Tennessee Health Science Center, Memphis, Tennessee, USA. His research interests include pulmonary infectious and inflammatory diseases, pediatric pharmacotherapy and the application of quantitative modeling and simulation techniques in preclinical and clinical drug development, with specific focus on therapeutic proteins. His research work has attracted more than $40 million in extramural funding as principal and co-investigator and has resulted in over 180 scientific papers and book chapters (h-index 46), three textbooks, and over 200 invited scientific presentations to national and international audiences. Dr. Meibohm is a Fellow of the American Association of Pharmaceutical Scientists (AAPS) and American College of Clinical Pharmacology (ACCP). He is a past president of ACCP and is currently serving as associate editor for The AAPS Journal, and on the editorial boards the Journal of Clinical Pharmacology, Clinical Pharmacokinetics, the Journal of Pharmacokinetics and Pharmacodynamics, and several other scientific publications.  

Johan Gabrielsson, Ph.D. is a Professor of Integrative Pharmacology in Uppsala, Sweden. He served as Senior Principal Scientist at AstraZeneca R&D between 2002-2012. His responsibilities included preclinical PK/PD projects in the GI & CV, CNSP, Oncology and Infection areas as well as biological data analysis. He is the author of the textbooks ‘Pharmacokinetic and Pharmacodynamic Data Analysis: Concepts and Applications’ 5th ed. (2016) and ‘Quantitative Pharmacology: An Introduction to Integrative PKPD Analysis’ (2012). He has published extensively in the field of pharmacokinetic-pharmacodynamic modeling and reasoning and has run courses in the area of biological data analysis (>6000 participants) since 1984. He acts as an independent teacher and consultant.